ICD-10-CM Billable Code

E10.351

Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema

Clinical Classification Guidelines

Medical Intelligence & Overview

Type 1 diabetes mellitus is a chronic condition where the body’s immune system attacks insulin-producing cells in the pancreas. This results in high blood sugar levels that require lifelong management. One serious complication associated with long-term diabetes is diabetic retinopathy, a condition affecting the eye's retina. Specifically, E10.351 refers to cases where proliferative diabetic retinopathy occurs alongside macular edema, leading to potential vision problems. Understanding this condition can help patients recognize its significance and the importance of proper monitoring and treatment.

Causes & Symptoms

Clinical Causes: Autoimmune reaction leading to destruction of pancreatic insulin-producing cells Chronic high blood sugar levels damaging small blood vessels in the eyes Duration of diabetes, with longer disease course increasing risk Poor blood sugar control over time Presence of hypertension or high blood pressure that accelerates vascular damage

Key Symptoms: Gradual vision loss or blurriness Sudden vision changes or floaters Distorted vision, especially in the central visual field Dark spots or shadowing in parts of the vision Difficulty seeing at night or in low light conditions

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves comprehensive eye examinations, including dilated fundus exams where the eye doctor examines the retina closely. Instruments like fundus photography and optical coherence tomography (OCT) can detect the presence of proliferative retinopathy and macular edema. Blood tests are also essential to assess blood sugar control and overall diabetes management status. Regular retinal screenings are recommended for individuals with type 1 diabetes to catch any early signs of eye complications.

Treatment Protocols: Managing diabetic retinopathy with macular edema involves a combination of approaches aimed at controlling blood sugar levels and addressing eye-specific issues. Treatment options include: - **Blood sugar management:** Tight control of blood glucose can slow the progression of retinopathy. - **Laser therapy:** Focal or scatter laser treatment to seal leaking blood vessels and reduce edema. - **Injections:** Anti-VEGF (vascular endothelial growth factor) injections can decrease abnormal blood vessel growth and reduce swelling. - **Surgical interventions:** Vitrectomy may be necessary if bleeding or retinal detachment occurs. - **Routine eye exams:** Regular monitoring helps track disease progression and adjust treatments promptly. Patients should work closely with their healthcare providers to develop a personalized management plan to preserve vision and overall health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E10.351 a billable ICD-10 code?
Yes, E10.351 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E10.351?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

proliferative macular edema diabetic retinopathy mellitus diabetes